Hong Kong
· Delayed Price · Currency is HKD Lepu Biopharma Statistics
Total Valuation
Lepu Biopharma has a market cap or net worth of HKD 4.93 billion. The enterprise value is 5.13 billion.
| Market Cap | 4.93B |
| Enterprise Value | 5.13B |
Important Dates
The next estimated earnings date is Thursday, November 21, 2024.
| Earnings Date | Nov 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Lepu Biopharma has 1.71 billion shares outstanding. The number of shares has increased by 0.31% in one year.
| Shares Outstanding | 1.71B |
| Shares Change (YoY) | +0.31% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 35.28% |
| Owned by Institutions (%) | 4.47% |
| Float | 645.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.76 |
| PB Ratio | 5.01 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -65.68 |
| EV / Sales | 23.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 85.91.
| Current Ratio | 0.75 |
| Quick Ratio | 0.73 |
| Debt / Equity | 85.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.86 |
Financial Efficiency
Return on equity (ROE) is -10.26% and return on invested capital (ROIC) is -17.06%.
| Return on Equity (ROE) | -10.26% |
| Return on Assets (ROA) | -11.33% |
| Return on Capital (ROIC) | -17.06% |
| Revenue Per Employee | 448,798 |
| Profits Per Employee | -158,925 |
| Employee Count | 429 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.63% in the last 52 weeks. The beta is -0.45, so Lepu Biopharma's price volatility has been lower than the market average.
| Beta (5Y) | -0.45 |
| 52-Week Price Change | -45.63% |
| 50-Day Moving Average | 2.94 |
| 200-Day Moving Average | 3.68 |
| Relative Strength Index (RSI) | 49.47 |
| Average Volume (20 Days) | 2,529,958 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Lepu Biopharma had revenue of HKD 220.36 million and -78.03 million in losses. Loss per share was -0.05.
| Revenue | 220.36M |
| Gross Profit | 173.55M |
| Operating Income | -471.44M |
| Pretax Income | -91.72M |
| Net Income | -78.03M |
| EBITDA | -381.20M |
| EBIT | -471.44M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 620.27 million in cash and 832.61 million in debt, giving a net cash position of -212.34 million or -0.12 per share.
| Cash & Cash Equivalents | 620.27M |
| Total Debt | 832.61M |
| Net Cash | -212.34M |
| Net Cash Per Share | -0.12 |
| Equity (Book Value) | 969.21M |
| Book Value Per Share | 0.57 |
| Working Capital | -259.74M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.76%, with operating and profit margins of -213.94% and -35.41%.
| Gross Margin | 78.76% |
| Operating Margin | -213.94% |
| Pretax Margin | -41.62% |
| Profit Margin | -35.41% |
| EBITDA Margin | -172.99% |
| EBIT Margin | -213.94% |
| FCF Margin | n/a |
Dividends & Yields
Lepu Biopharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.31% |
| Shareholder Yield | -0.31% |
| Earnings Yield | -1.63% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |